SCHEMBL29630913

SCHEMBL29630913

O=C(NC1CC2(C1)CC(c1nc3cc(Cl)ccc3o1)C2)C1CCS(=O)(=O)CC1

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PTGES O14684 20/20 0.50
▸ PTGS2 P35354 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26225713 1.00 PTGES (0.50) PTGESPTGS2
SCHEMBL26225779 1.00 PTGES (0.50) PTGESPTGS2
SCHEMBL26225689 0.94 PTGES (0.46) PTGESPTGS2
SCHEMBL29895625 0.90 PTGES (0.47) PTGESPTGS2
SCHEMBL26225706 0.90 PTGES (0.47) PTGESPTGS2
SCHEMBL26225722 0.89 NPC1 (0.45) PTGESPTGS2
SCHEMBL29630854 0.89 PTGES (0.46) PTGESPTGS2
SCHEMBL26225711 0.89 PTGES (0.46) PTGESPTGS2
SCHEMBL24473842 0.88 PTGES (0.56) PTGESPTGS2
SCHEMBL24473912 0.88 PTGES (0.56) PTGESPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457352-A Aryloxazolo spiro derivatives for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2023-07-18 — — CN claimed
EP-4251623-A1 ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2023-10-04 — — EP disclosed
CN-116457352-A Aryloxazolo spiro derivatives for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2023-07-18 — — CN disclosed
WO-2022112140-A1 ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 — — WO disclosed
Send feedback